Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AddLife is an active Swedish life science group headquartered in Stockholm, operating as an independent partner in the European life science sector. It acquires and manages approximately eighty-five entrepreneur-driven subsidiaries focused on medtech devices/equipment/distribution and laboratory diagnostics/research solutions across Europe. The company provides high-quality products and services for healthcare and research, distributing medical technology products (including some self-manufactured items) and offering related advisory/training services to hospitals, laboratories, academic institutions, pharma companies, and home care providers. It does not conduct clinical trials or develop drugs/biologics, but reports strong organic growth. With over SEK 10 billion (~$950M USD) annual revenue and approximately 2300 employees, it has a strong presence across thirty European countries, particularly in the Nordics. Its shares trade under "ALIF B" on Nasdaq Stockholm since March 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AddLife.